Clinical Trial Update: Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication

View source ↗

Summary

A completed clinical trial evaluating whether twice-daily versus four-times-daily amoxicillin improves outcomes in tegoprazan-based Helicobacter pylori eradicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Takecab (tegoprazan)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: H.Pylori Infection | Status: COMPLETED